During 1981-89,as a senior researcher,he was focused on Haemostasis and Thrombosis in clinics. In 1986-89,he completed MSc degree under the help of professor RM Bertina and AW Broekmans at Haemostasis and Thrombosis Research Unit of University Hospital Leiden in The Netherlands. His studies was in the area of human plasma protein C. In 1989-now, he is the inventor of oncogenic receptor in fresh insight on tumor molecular biology and pharmacology.Targeting oncogenic receptor is currently the third-setting,and currently the standard of care in hospital worldwide.He is also the discover of gene regulation of retinoic acid action(retinoid pharmacology),and work involved in the research on natural anti-tumor drugs.He has over 20 original scientific articles in international peer-reviewed journals and patents to his credit.

Drug discovery,Tumors and/cancers, Thyroid disorders, Chronic disease, target therapy(targeting oncogenic receptor in tumours), traditional medicine